Articles
Page 3 of 19
-
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P235
-
High plasma levels of parathyroid hormone (PTH) are associated with an increased cardiovascular risk among HIV-infected subjects
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P233 -
Smoking prevalence, cessation rates and relapse rates in the Swiss HIV Cohort Study (SHCS)
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P231 -
Abstract withdrawn
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P229 -
Therapeutics designed to neutralize soluble HIV tat protein could preserve IL-7 signaling and CD8 T-cell function in HIV+ patients
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P227 -
No effect of a single supratherapeutic dose of lersivirine, a next-generation NNRTI, on QTc interval in healthy subjects
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P225 -
Acute hepatitis C in persons infected with the human immunodeficiency virus (HIV): the 'real-life setting' proves the concept
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P202 -
Increasing numbers of acute hepatitis C infections in HIV-infected MSM and high reinfection rates following SVR
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P200 -
Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P199 -
Enfuvirtide in therapy at patients with HIV-infection and tuberculosis
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P197 -
Generalized tuberculosis in HIV-infected patients with AIDS
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P195 -
Epidemiology of HIV-associated tuberculosis (TB) co-infection in Krasnoyarsk region, Russian Federation
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P193 -
The use of a darunavir/ritonavir once-daily regimen in two pregnant women
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P189 -
BEST: Better Equipped to Start Treatment
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P166 -
Pregnancy decisions and contraceptive use among HIV-positive women: a study in a large urban clinic in sub-Saharan Africa
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P164 -
A complex of measures effectiveness in reducing mother-to-child HIV transmission
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P162 -
Antiretroviral strategies for the treatment of pregnant HIV+ women and prevention of perinatal HIV transmission in Dodoma, Tanzania: AMANI Study
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P160 -
High preterm delivery rates associated with initiation of HAART during pregnancy
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P158 -
Audit of outcomes of early initiation of antiretroviral therapy in children admitted to the paediatric wards at Kilifi district hospital, Kenya
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P156 -
Feasibility and effectiveness of combination antiretroviral therapy in HIV-infected infants in Pietermaritzburg, South Africa
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P154 -
Analysis of major and minor IAS-USA PI mutations in the MONET trial of darunavir/ritonavir monotherapy versus DRV/r + 2NRTIs
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P131 -
Detection of HIV type 1 mutations on the pol region in untreated patients in Northern Vietnam: determination of drug resistance and subtypes
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P127 -
Transmitted drug resistance associated with transmission clusters in newly diagnosed antiretroviral-naïve patients in Northern Greece
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P125 -
High level of adherence to HAART among refugees and internally displaced persons on HAART in western equatorial region of Southern Sudan
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P123 -
Antiretroviral regimen complexity as a predictor of adherence
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P121 -
Changing HIV guidelines: how to communicate treatment start
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P117 -
Fracture risk in HIV and the need for guidelines: the Probono-1 Trial
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P99 -
Markers of bone turnover are elevated in patients on antiretrovirals independent of the substance used
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P97 -
Toxic intracellular anabolite levels of tenofovir and didanosine causing a steep CD4-cell decline
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P95 -
Mesenteric fat thickness in a group of HIV patients on HAART
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P72 -
Alexithymia, an impairment of emotional cognitive processing, is a candidate risk factor for carotid artery plaque formation in HIV-infected patients
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P70 -
Nitric oxide protects against HIV gp120 endothelial injury
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P68 -
Low serum phosphate levels are related to increased cardiovascular risk in HIV-1 infected patients
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P66 -
Cardiovascular risk in patients visiting the Hadassah AIDS Center, Jerusalem
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P64 -
Role of platelet activation in the cardiovascular complications associated with HIV infection: differential effect of abacavir versus tenofovir
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P62 -
A comparison of the FDA TLOVR and FDA Snapshot algorithms based on studies evaluating once-daily vs. twice daily lopinavir/ritonavir (LPV/r) regimens
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P58 -
Reasons for using and efficacy of raltegravir in salvage regimens without protease inhibitors in clinical practice
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P35 -
Switching to a 'nuke-sparing' raltegravir/atazanavir combination: an individualised approach
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P33 -
Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P29 -
Darunavir in experienced patients
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P27 -
0231. Growing old with HIV — dealing with co-morbidities
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O25 -
0222. Major issues and their solutions in the management of HIV and TB — from the laboratory to the patient and population
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O23 -
O213. Low-level viraemia during treatment with darunavir/r monotherapy versus DRV/r + 2NRTIs in the MONET trial
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O19 -
Epidemiological features, therapeutic strategies and long-term immunological outcomes in virologically suppressed HIV+ very late presenters
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P19 -
O211. The state of PI monotherapy and NRTI-sparing therapy
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O17 -
O134. HIV treatment as prevention — human rights issues
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O15 -
Nevirapine (NVP) vs ritonavir-boosted atazanavir (ATV/r) combined with tenofovir/emtricitabine (TDF/FTC) in first-line therapy: NEWART 48-week data
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P4 -
O114. Long-term probability of detecting drug-resistant HIV in patients starting antiretroviral therapy within the first year of HIV infection
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O4 -
The management of acute retroviral syndrome
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P2 -
O112. International perspectives on adherence and resistance to HIV antiretroviral therapy
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O2